Cargando…

Cytokine production in Ancylostoma duodenale infection

Cytokine response to Ancylostoma duodenale (A. duodenale) infection was measured after starting treatments with piperazine. This study aims to determine the impact of cytokine production after infection with A. duodenale before and after treatment with piperazine. Blood and stool samples of 50 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Shlash, Shaimaa Abdulhussein, Alzubaidi, Zubaida Falih, Saleh, Huda Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126450/
https://www.ncbi.nlm.nih.gov/pubmed/35646178
http://dx.doi.org/10.25122/jml-2021-0383
_version_ 1784712132115300352
author Shlash, Shaimaa Abdulhussein
Alzubaidi, Zubaida Falih
Saleh, Huda Ali
author_facet Shlash, Shaimaa Abdulhussein
Alzubaidi, Zubaida Falih
Saleh, Huda Ali
author_sort Shlash, Shaimaa Abdulhussein
collection PubMed
description Cytokine response to Ancylostoma duodenale (A. duodenale) infection was measured after starting treatments with piperazine. This study aims to determine the impact of cytokine production after infection with A. duodenale before and after treatment with piperazine. Blood and stool samples of 50 patients with A. duodenale infection and 28 healthy individuals (control) were collected. In this study, IFNγ, IL-5, IL-12, and IL-13 in serum (using ELISA-based methods) were measured. Stool samples were examined using the Kato-Katz technique to detect A. duodenale parasites. Blood and stool samples were analyzed 14 days after starting piperazine treatment for A. duodenale infection. The medium concentration of IFNγ, IL-5, IL-12, and IL-13 in the serum samples with A. duodenale infection is higher than that of the control group. IFNγ, IL-5, IL-12, and IL-13 levels were significantly higher in the infected individuals (10.5±7.4 pg/ml, 14.6±5.1 pg/ml, 8.5±3.2 pg/ml and 13.6±7.5 pg/ml respectively) than the control group (4.7±2.4 pg/ml, 7.8±4.06 pg/ml, 6.3±3.4 pg/ml and 3.5±2.7 pg/ml respectively). Also, piperazine treatment can significantly reduce cytokines levels (IFN-γ: P=0.043, IL-5: P=0.02, and IL-12, p=0.001). This study shows that piperazine treatment can reduce cytokines profiles in patients with A. duodenale infection.
format Online
Article
Text
id pubmed-9126450
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-91264502022-06-01 Cytokine production in Ancylostoma duodenale infection Shlash, Shaimaa Abdulhussein Alzubaidi, Zubaida Falih Saleh, Huda Ali J Med Life Original Article Cytokine response to Ancylostoma duodenale (A. duodenale) infection was measured after starting treatments with piperazine. This study aims to determine the impact of cytokine production after infection with A. duodenale before and after treatment with piperazine. Blood and stool samples of 50 patients with A. duodenale infection and 28 healthy individuals (control) were collected. In this study, IFNγ, IL-5, IL-12, and IL-13 in serum (using ELISA-based methods) were measured. Stool samples were examined using the Kato-Katz technique to detect A. duodenale parasites. Blood and stool samples were analyzed 14 days after starting piperazine treatment for A. duodenale infection. The medium concentration of IFNγ, IL-5, IL-12, and IL-13 in the serum samples with A. duodenale infection is higher than that of the control group. IFNγ, IL-5, IL-12, and IL-13 levels were significantly higher in the infected individuals (10.5±7.4 pg/ml, 14.6±5.1 pg/ml, 8.5±3.2 pg/ml and 13.6±7.5 pg/ml respectively) than the control group (4.7±2.4 pg/ml, 7.8±4.06 pg/ml, 6.3±3.4 pg/ml and 3.5±2.7 pg/ml respectively). Also, piperazine treatment can significantly reduce cytokines levels (IFN-γ: P=0.043, IL-5: P=0.02, and IL-12, p=0.001). This study shows that piperazine treatment can reduce cytokines profiles in patients with A. duodenale infection. Carol Davila University Press 2022-04 /pmc/articles/PMC9126450/ /pubmed/35646178 http://dx.doi.org/10.25122/jml-2021-0383 Text en ©2022 JOURNAL of MEDICINE and LIFE https://creativecommons.org/licenses/by/3.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Original Article
Shlash, Shaimaa Abdulhussein
Alzubaidi, Zubaida Falih
Saleh, Huda Ali
Cytokine production in Ancylostoma duodenale infection
title Cytokine production in Ancylostoma duodenale infection
title_full Cytokine production in Ancylostoma duodenale infection
title_fullStr Cytokine production in Ancylostoma duodenale infection
title_full_unstemmed Cytokine production in Ancylostoma duodenale infection
title_short Cytokine production in Ancylostoma duodenale infection
title_sort cytokine production in ancylostoma duodenale infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126450/
https://www.ncbi.nlm.nih.gov/pubmed/35646178
http://dx.doi.org/10.25122/jml-2021-0383
work_keys_str_mv AT shlashshaimaaabdulhussein cytokineproductioninancylostomaduodenaleinfection
AT alzubaidizubaidafalih cytokineproductioninancylostomaduodenaleinfection
AT salehhudaali cytokineproductioninancylostomaduodenaleinfection